EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieVergleichsstudie

Efficacy and safety of interactive digital therapeutics with cognitive behavioral therapy for depressive symptoms in patients with major depressive disorder: A multicenter, randomized, assessor-blinded trial versus an active mood diary control

Yoo Jin Jang, Woojae Myung, C Hyung Keun Park, Hong Jin Jeon

Journal of Affective Disorders · 2027-01 · 417 · 122653

DOI: 10.1016/j.jad.2026.122653 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Affective Disorders, 2027-01. Verfasst von Yoo Jin Jang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Kore…. Hauptthemen laut MEDLINE: Affect, Cognitive Behavioral Therapy, Digital Media, Major Depressive Disorder. Die Arbeit nennt 18 Literaturangaben. Gefördert von: Korea Ministry of Health and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Digital cognitive behavioral therapy (CBT) is effective for major depressive disorder, but many interventions use static, non-interactive content. Interactive digital therapeutics with CBT (iDT-CBT) provides adaptive, dialogue-based interventions. METHODS: We conducted an 8-week randomized, assessor-blinded trial comparing iDT-CBT with an active mood diary control in 110 adults with major depressive disorder. The primary outcome was change in BDI-II score at Week 8. Secondary outcomes included PHQ-9, MADRS, and BAI. Analyses included all randomized participants, using analysis of covariance adjusted for baseline score and sex. RESULTS: BDI-II improvement was greater with iDT-CBT than with the active mood diary (13.34 vs. 6.54 points; adjusted p = 0.0003). PHQ-9, MADRS, and BAI improvements also favored iDT-CBT. Week 8 remission proportions were higher with iDT-CBT for BDI-II (30.4% vs. 9.3%), PHQ-9 (62.5% vs. 44.4%), MADRS (23.2% vs. 5.6%), and BAI (50.0% vs. 20.4%). In logistic regression adjusted for baseline score and sex, the conditional odds of remission favored iDT-CBT for all four outcomes (p = 0.011, 0.039, 0.014, and 0.002, respectively), although the unadjusted risk-difference confidence interval for PHQ-9 included zero. However, the BDI-II effect was attenuated in the site-adjusted mixed model for repeated measures (MMRM), and BDI-II and PHQ-9 effects were not significant in MMRM, multiple-imputation, or observed-case analyses. MADRS and BAI remained significant. No adverse-event-related discontinuations or intervention-related serious adverse events occurred. DISCUSSION: iDT-CBT showed promising short-term efficacy, although effects on self-reported depressive symptoms were sensitive to the analytical method. Longer-term studies are needed. CLINICAL TRIAL REGISTRATION: Clinical Research Information Service identifier: KCT0010758 (https://cris.nih.go.kr/cris/search/detailSearch.do?seq=30575).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AffectCognitive Behavioral TherapyDigital MediaMajor Depressive DisorderDigital HealthAdultFemaleHumansMaleMiddle AgedSingle-Blind MethodTreatment Outcome

Stichwörter der Autor:innen

Digital cognitive behavioral therapyInteractive digital therapeuticsMajor depressive disorderRandomized controlled trial

Autor:innen und Institutionen

  • Department of Psychiatry, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea.
  • Department of Psychiatry, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea; Department of Neuropsychiatry, Seoul National University Bundang Hospital, Seongnam, 13620, Republic of Korea.
  • Department of Psychiatry, Asan Medical Center, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
  • Department of Psychiatry, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea; Department of Health Sciences & Technology, Samsung Advanced Instit…

Förderung

  • Korea Ministry of Health and Welfare

Zitieren

APA

Jang, Y. J., Myung, W., Park, C. H. K., & Jeon, H. J. (2027). Efficacy and safety of interactive digital therapeutics with cognitive behavioral therapy for depressive symptoms in patients with major depressive disorder: A multicenter, randomized, assessor-blinded trial versus an active mood diary control. Journal of Affective Disorders, 417, 122653. https://doi.org/10.1016/j.jad.2026.122653

Vancouver

Jang YJ, Myung W, Park CHK, Jeon HJ. Efficacy and safety of interactive digital therapeutics with cognitive behavioral therapy for depressive symptoms in patients with major depressive disorder: A multicenter, randomized, assessor-blinded trial versus an active mood diary control. Journal of Affective Disorders. 2027;417:122653. doi:10.1016/j.jad.2026.122653

BibTeX
@article{Jang2027,
  author = {Jang, Yoo Jin and Myung, Woojae and Park, C Hyung Keun and Jeon, Hong Jin},
  title = {Efficacy and safety of interactive digital therapeutics with cognitive behavioral therapy for depressive symptoms in patients with major depressive disorder: A multicenter, randomized, assessor-blinded trial versus an active mood diary control},
  journal = {Journal of Affective Disorders},
  year = {2027},
  volume = {417},
  pages = {122653},
  doi = {10.1016/j.jad.2026.122653}
}
Kostenlos starten →